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Background: The upper gastrointestinal tract plays a prominent role in human physiology as the primary site for
enzymatic digestion and nutrient absorption, immune sampling, and drug uptake. Alterations to the small intestine
microbiome have been implicated in various human diseases, such as non-alcoholic steatohepatitis and
inflammatory bowel conditions. Yet, the physiological and functional roles of the small intestine microbiota in
humans remain poorly characterized because of the complexities associated with its sampling. Rodent models are
used extensively in microbiome research and enable the spatial, temporal, compositional, and functional
interrogation of the gastrointestinal microbiota and its effects on the host physiology and disease phenotype.
Classical, culture-based studies have documented that fecal microbial self-reinoculation (via coprophagy) affects the
composition and abundance of microbes in the murine proximal gastrointestinal tract. This pervasive self-
reinoculation behavior could be a particularly relevant study factor when investigating small intestine microbiota.
Modern microbiome studies either do not take self-reinoculation into account, or assume that approaches such as
single housing mice or housing on wire mesh floors eliminate it. These assumptions have not been rigorously
tested with modern tools. Here, we used quantitative 16S rRNA gene amplicon sequencing, quantitative microbial
functional gene content inference, and metabolomic analyses of bile acids to evaluate the effects of self-
reinoculation on microbial loads, composition, and function in the murine upper gastrointestinal tract.
Results: In coprophagic mice, continuous self-exposure to the fecal flora had substantial quantitative and
qualitative effects on the upper gastrointestinal microbiome. These differences in microbial abundance and
community composition were associated with an altered profile of the small intestine bile acid pool, and,
importantly, could not be inferred from analyzing large intestine or stool samples. Overall, the patterns observed in
the small intestine of non-coprophagic mice (reduced total microbial load, low abundance of anaerobic microbiota,
and bile acids predominantly in the conjugated form) resemble those typically seen in the human small intestine.
Conclusions: Future studies need to take self-reinoculation into account when using mouse models to evaluate
gastrointestinal microbial colonization and function in relation to xenobiotic transformation and pharmacokinetics
or in the context of physiological states and diseases linked to small intestine microbiome and to small intestine
dysbiosis.
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The small intestine is the primary site for enzymatic di-
gestion and nutrient uptake, immune sampling, and drug
absorption in the human gastrointestinal system. Its
large surface area vastly exceeds that of the large intes-
tine [1], and thus may serve as a broad interface for
host-microbial interactions.
A growing body of scientific evidence highlights the
importance of the small intestine microbiome in normal
human physiology and response to dietary interventions
[2, 3]. Alterations in the small intestine microbiome are
implicated in a number of human disorders, such as
malnutrition [4, 5], obesity, and metabolic disease [6], in-
flammatory bowel disease (IBD) and irritable bowel syn-
drome (IBS) [7–9], and drug side effects [10]. Despite
the apparent importance of the small intestine micro-
biome in human health, it remains understudied and
poorly characterized largely because of the procedural
and logistical complexities associated with its sampling
in humans (methods are too invasive and require spe-
cialized healthcare facilities). Moreover, microbial com-
position tends to differ substantially among the small
intestine, large intestine, and stool of the same animal or
human subject [11, 12], which highlights the importance
of targeted sampling of the small intestine for analyses.
Mice are the predominant animal species of model or-
ganisms in the field of microbiome research. Compared
with other mammalian models, mice have a lower cost
of maintenance, their environment and diet can be easily
controlled, they are amenable to genetic manipulation,
there are numerous genetic mouse models already avail-
able, and propagation using inbred colonies reduces
inter-individual variability [13]. Additionally, murine
germ-free (GF) and gnotobiotic technologies are well
established. Using mouse models enables interrogation
of the entire gastrointestinal tract (GIT) and examin-
ation of the changes in microbiome and host physiology
that occur in response to experimental conditions (e.g.,
dietary modifications, xenobiotic administration) or mi-
crobial colonization (e.g., monocolonization, colonization
with defined microbial consortia, human microbiota-
associated mice).
Rodent models also have several well-recognized limita-
tions associated with their genetic, anatomical, and
physiological differences with humans [13, 14]. Among
these limitations is the persistent tendency of rodents to
practice gastrointestinal auto- and allo-reinoculation with
large intestine microbiota (via fecal ingestion, or
coprophagy) in laboratory settings [15–17]. This pervasive
behavior has been documented in classical studies using
observational techniques in both conventional and GF
mice [18], in conventional mice maintained on standard
and fortified diets [19], in animals with and without access
to food [20], and across different mouse strains [16, 21].Multiple classical studies have attempted to evaluate
the effects of self-reinoculation on the structure of the
microbiota in the rodent small intestine [22–24] and
large intestine and stool [20, 23, 25, 26] using traditional
microbiological techniques, but reported conflicting re-
sults [23, 25, 26]. This lack of consensus may be attrib-
uted to the use of different methods for preventing
coprophagy (some of which are ineffective), non-
standardized diets, inter-strain or inter-species differ-
ences among the animal models, or other unaccounted
for experimental parameters. It has been also suggested
that repeated self-exposure in mice via coprophagy can
promote microbial colonization of the GIT by “exogen-
ous” microbial species, such as Pseudomonas spp. [27].
All of these observations highlight the importance of
considering self-reinoculation in studies of gastrointes-
tinal microbial ecology in murine models. However, the
field currently lacks precise and comprehensive evalua-
tions of the effects of self-reinoculation on the spatial,
structural, and functional state of the gut microbiome
and its effects on murine host physiology. Current
microbiome studies in rodents either do not take self-
reinoculation into account, or assume it can be elimi-
nated by single housing of animals or housing them on
wire mesh floors (also referred to as “wire screens” or
“wire grids”) [14]. Despite classical literature suggesting
these assumptions can be incorrect [16, 21, 28–32], they
have not been tested on mice housed in modern facilities
using state-of-the-art quantitative tools.
Here, we explicitly test these assumptions about mur-
ine self-reinoculation to answer the following three
questions relevant to gastrointestinal microbiome re-
search: (1) Do quantitative 16S rRNA gene amplicon se-
quencing tools detect differences in small intestine
microbial loads between mice known to be coprophagic
and non-coprophagic? (2) Does coprophagy impact the
microbial composition of the small intestine? (3) Do dif-
ferences in microbiota density and composition associ-
ated with self-reinoculation in mice impact microbial
function (e.g., alter microbial metabolite production or
modifications) in the small intestine?
To answer these questions, we analyzed gastrointes-
tinal samples from mice under conditions known to pre-
vent coprophagy (fitting with “tail” or “fecal collection”
cups [16, 23, 26, 30, 33]) and typical laboratory condi-
tions in which mice are known to be coprophagic (hous-
ing in standard cages). We also included samples from
single-housed mice in standard and wire-floor cages. We
analyzed the quantitative and compositional changes in
the microbiome along the entire length of the mouse
GIT in response to self-reinoculation, computationally
inferred the changes in microbial function, and evaluated
the microbial function-related metabolite profiles in the
corresponding segments of the gut.
Bogatyrev et al. Microbiome            (2020) 8:19 Page 3 of 22Results
We first performed a pilot study to confirm that pre-
venting coprophagy in mice would result in decreased
viable microbial load and altered microbiota compos-
ition in the small intestine. We used a most probable
number (MPN) assay utilizing anaerobic BHI-S broth
medium to evaluate the live (culturable) microbial loads
along the entire GIT of mice known to be coprophagic
(housed in standard cages in groups, N = 5) and mice
known to be non-coprophagic (fitted with tail cups and
housed in standard cages in groups, N = 5). Consistent
with the published classical literature [20, 24], we found
that coprophagic mice had significantly higher loads of
culturable microbes in their upper GIT than mice that
were non-coprophagic (Additional file 1: Figure S4A).
Moreover, the microbial community composition in the
proximal GIT, particularly in the stomach, of copropha-
gic mice more closely resembled the microbial compos-
ition of the large intestine (Additional file 1: Figure S4B)
as revealed by 16S rRNA gene amplicon sequencing
(N = 1 mouse analyzed from each group) and principal
component analysis (PCA) of the resulting relative abun-
dance data.
This pilot study confirmed that in our hands, tail cups
were effective at preventing the self-reinoculation ofFig. 1 An overview of the study design and timeline. a Mice from two age
mice to a cage) for 2–6 months. One mouse from each cage was then ass
(TC-F), mock tail cups (TC-M), housing on wire floors (WF), and controls hou
maintained on each treatment for 12–20 days (N = 24, 6 mice per group). b
tract. Each sample was analyzed by quantitative 16S rRNA gene amplicon s
quantitative bile-acid analyses of CNT. Panel b is adapted from [13, 34])viable fecal flora in the upper GIT of mice. These results
spurred us to design a rigorous, detailed study (Fig. 1) to
answer the three questions posed above using state-of-
the-art methods: quantitative 16S rRNA gene amplicon
sequencing (to account for both changes in the total mi-
crobial load and the unculturable taxa), quantitative
functional gene content inference, and targeted bile-acid
metabolomics analyses.
The study design (Fig. 1) consisted of six cages of four
animals each that were co-housed for 2–6 months and
then split into four experimental groups and singly
housed for 12–20 days. The four experimental condi-
tions were the following: animals fitted with functional
tail cups (TC-F) and singly housed in standard cages, an-
imals fitted with mock tail cups (TC-M) and singly
housed in standard cages, animals singly housed on wire
floors (WF), and control animals singly housed in stand-
ard conditions (CTRL). At the end of the study, gastro-
intestinal contents and mucosal samples were collected
from all segments of the GIT of each animal and we
evaluated total microbial loads (entire GIT) and micro-
biome composition (stomach (STM), jejunum (SI2), and
cecum (CEC)).
We chose the cecum segment of the large intestine for
quantitative 16S rRNA gene amplicon sequencingcohorts (4-month-old and 8-month-old) were raised co-housed (four
igned to one of the four experimental conditions: functional tail cups
sed in standard conditions (CTRL). All mice were singly housed and
Samples were taken from six sites throughout the gastrointestinal
equencing of lumenal contents (CNT) and mucosa (MUC) and/or
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provide a complete snapshot of the large intestine and
fecal microbial diversity in response to environmental
factors [35–37]. Cecal contents also enabled us to collect
a more consistent amount of sample from all animals
across all experimental conditions (whereas defecation
may be inconsistent among animals at the time of ter-
minal sampling).Self-reinoculation increases microbial loads in the upper
gut
To answer our first question (Can quantitative sequen-
cing tools detect the difference in 16S rRNA gene DNA
copy load in the upper GIT of mice known to be copro-
phagic and non-coprophagic?), we analyzed total quanti-
fiable microbial loads across the GIT using 16S rRNA
gene DNA quantitative PCR (qPCR) and digital PCR
(dPCR). Preventing self-reinoculation in mice equipped
with functional tail cups dramatically decreased the lu-
menal microbial loads in the upper GIT but not in the
lower GIT (Fig. 2a). Total quantifiable microbial loads in
the upper GIT were reduced only in mice equipped with
functional tail cups. All other experimental groups of
singly-housed animals (those equipped with mock tail
cups, housed on wire floors, or housed on standard
woodchip bedding) that retained access to fecal matter
and practiced self-reinoculation had similarly high mi-
crobial loads in the upper GIT, as expected from the
published literature [16, 21, 28–32].
Across all test groups, mucosal microbial loads in the
mid-small intestine demonstrated high correlationFig. 2 Quantification of microbial loads in lumenal contents and mucosa o
conditions: functional tail cups (TC-F), mock tail cups (TC-M), housing on w
Total 16S rRNA gene DNA copy loads, a proxy for total microbial loads, we
upper third of the small intestine (SI), SI2 =middle third of the SI, SI3 = low
and ileum respectively; CEC = cecum; COL = colon). Multiple comparisons w
comparisons using the Wilcoxon–Mann–Whitney test with false-discovery r
whisker plots; whiskers extend from the quartiles (Q2 and Q3) to the last d
the microbial loads in the lumenal contents (per gram total contents) and
per experimental group(Pearson’s R = 0.84, P = 2.8 × 10− 7) with the microbial
loads in the lumenal contents (Fig. 2b).
Stomach (STM) and small intestine (SI1, SI2, and SI3)
samples from one (out of six) of the TC-F mice showed
higher microbial loads compared with the other TC-F
mice. The total microbial load in the upper GIT in this
TC-F mouse was similar to mice from all other groups
(TC-M, WF, CTRL), which emphasizes the crucial im-
portance of performing analyses of both microbial load
and composition (discussed below) on the same samples.Self-reinoculation substantially alters the microbiota
composition in the upper gut but has less pronounced
effects in the large intestine
To answer our second question (Does self-reinoculation
with fecal microbiota impact upper GIT microbial com-
position?), we performed quantitative 16S rRNA gene
amplicon sequencing [38, 39] (Barlow JT, Bogatyrev SR,
Ismagilov RF: A quantitative sequencing framework for
absolute abundance measurements of mucosal and lu-
menal microbial communities, submitted) on the stom-
ach (STM), jejunum (SI2), and cecum (CEC) samples.
Qualitative sequencing revealed dramatic overall changes
in the upper GIT microbiota caused by self-
reinoculation (Fig. 3). An exploratory PCA performed on
the multidimensional absolute microbial abundance pro-
files highlights the unique and distinct composition of the
upper GIT microbiome of non-coprophagic mice (Fig.
3a). It is noteworthy that the stomach (STM) and small in-
testine (SI2) microbiota in all coprophagic mice clustered
closer to the large intestine microbiota, suggesting thef the gastrointestinal tracts (GIT) of mice in the four experimental
ire floors (WF), and controls housed in standard conditions (CTRL). a
re measured along the GIT of mice of all groups (STM = stomach; SI1 =
er third of the SI roughly corresponding to the duodenum, jejunum,
ere performed using a Kruskal–Wallis test, followed by pairwise
ate (FDR) correction. Individual data points are overlaid onto box-and-
ata point within 1.5 × interquartile range (IQR). b Correlation between
in the mucosa (per 100 ng of mucosal DNA) of the mid-SI. N = 6 mice
Fig. 3 (See legend on next page.)
Bogatyrev et al. Microbiome            (2020) 8:19 Page 5 of 22
(See figure on previous page.)
Fig. 3 Compositional and quantitative 16S rRNA gene amplicon sequencing analysis of the gut microbiota. a Principal component analysis (PCA)
of the log10-transformed and standardized (mean = 0, SD = 1) absolute microbial abundance profiles in the stomach, mid-small intestine, and
cecum. Loadings of the top contributing taxa are shown for each principal component. b Mean relative and absolute abundance profiles of
microbiota in the mid-SI (order level) for all experimental conditions. Functional tail cups (TC-F), mock tail cups (TC-M), housing on wire floors
(WF), and controls housed in standard conditions (CTRL). N = 6 mice per experimental group, 4 of which were used for sequencing. c Absolute
abundances of microbial taxa (order level) compared between coprophagic and non-coprophagic mice along the mouse GIT. *Chloroplast and
*Richettsiales (mitochondria) represent 16S rRNA gene DNA amplicons from food components of plant origin. Multiple comparisons were
performed using the Kruskal–Wallis test
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large intestine microbiota (Fig. 3a).
Self-reinoculation had differential effects across microbial
taxa (Fig. 3c), which could be classified into three main cat-
egories depending on the pattern of their change as follows:
1. “Fecal taxa” (e.g., Clostridiales, Bacteroidales,
Erysipelotrichales) that either dropped significantly
or disappeared (fell below the lower limit of
detection [LLOD] of the quantitative sequencing
method [38] (Barlow JT, Bogatyrev SR, Ismagilov
RF: A quantitative sequencing framework for
absolute abundance measurements of mucosal and
lumenal microbial communities, submitted)) in the
upper GIT of non-coprophagic mice;
2. “True small intestine taxa” (e.g., Lactobacillales)
that remained relatively stable in the upper GIT in
non-coprophagic mice;
3. Taxa that had lower absolute abundance in the
cecum (e.g., Bacteroidales, Erysipelotrichales,
Betaproteobacteriales) of non-coprophagic (com-
pared with coprophagic) mice.
Overall, the composition of the small intestine micro-
biota of coprophagic mice was consistent with that pre-
viously reported in literature [35]. The upper GIT
microbiota in non-coprophagic mice was dominated by
Lactobacilli (Fig. 3c), known to be a prominent micro-
bial taxon in human small intestine microbiota [3, 40,
41]. Importantly, the compositional analysis showed that
the single TC-F mouse that had high microbial loads in
its stomach and small intestine had a microbial compos-
ition in those segments of the GIT similar (i.e., domi-
nated by Lactobacillales) to all other TC-F mice, and
very distinct from all coprophagic mice (Fig. 3b, c). The
PCA showed that the stomach and mid-small intestine
of this mouse clustered with the stomach and mid-small
intestine of all other TC-F mice (Fig. 3a).
Changes in the small intestine microbiota lead to
differences in inferred microbial functional gene content
We hypothesized that the quantitative and qualitative
changes in the small intestine microbiota induced by
self-reinoculation may result in altered microbialfunction [42, 43] and an altered metabolite profile, either
indirectly, as a result of functional changes in the micro-
biota, or directly via re-ingestion of fecal metabolites. To
understand how such alterations to microbiota would
impact microbial function in the small intestine, we next
aimed to predict how the absolute abundances of func-
tional microbial genes would be affected. We coupled
the pipeline for microbial functional inference based on
the 16S rRNA marker gene sequences (PICRUSt2) [44,
45] with our quantitative 16S rRNA gene amplicon se-
quencing approach [38] (Barlow JT, Bogatyrev SR, Isma-
gilov RF: A quantitative sequencing framework for
absolute abundance measurements of mucosal and lu-
menal microbial communities, submitted). We focused
our analysis on microbial functions that would be highly
relevant to small intestine physiology: microbial conver-
sion of host-derived bile acids and microbial modifica-
tion of xenobiotics.
We found that the inferred absolute abundances of a
number of microbial gene orthologs implicated in en-
zymatic hydrolysis of conjugated bile acids (bile salt
hydrolase, BSH [46–48]) and xenobiotic conjugates (e.g.,
beta-glucuronidase, arylsulfatase [49, 50]) in the stomach
and the small intestine of coprophagic mice were dra-
matically higher (in some cases by several orders of mag-
nitude) than in non-coprophagic mice (Fig. 4). This
difference was not observed in the cecum.
Changes in the small intestine microbiota induced by
self-reinoculation alter the bile acid profile
Bile acids are a prominent class of host-derived com-
pounds with multiple important physiological functions
and effects on the host and its gut microbiota [51, 52].
These host-derived molecules are highly amenable to
microbial modification in both the small and large intes-
tine [53]. The main microbial bile acid modifications in
the GIT include deconjugation, dehydrogenation, dehy-
droxylation, and epimerization [52]. Thus, we next per-
formed quantitative bile acid profiling along the entire
GIT to evaluate the effects of self-reinoculation on bile
acid composition.
The small intestine is the segment of the GIT that har-
bors the highest levels of bile acids (up to 10 mM) and
where they function in lipid emulsification and absorption
Fig. 4 Inference of microbial genes involved in bile-acid and xenobiotic conjugate modification along the GIT of coprophagic and non-
coprophagic mice. Inferred absolute abundance of the microbial genes encoding (a) bile salt hydrolases (cholylglycine hydrolases), (b) beta-
glucuronidases, and (c) arylsulfatases throughout the GIT (STM stomach, SI2 middle third of the small intestine (SI) roughly corresponding to the
jejunum, CEC cecum). KEGG orthology numbers are given in parentheses for each enzyme. In all plots, individual data points are overlaid onto
box-and-whisker plots; whiskers extend from the quartiles (Q2 and Q3) to the last data point within 1.5 × interquartile range (IQR). Multiple
comparisons were performed using the Kruskal–Wallis test; pairwise comparisons were performed using the Wilcoxon–Mann–Whitney test with
FDR correction. N = 4 mice per group
Fig. 5 Bile acid profiles in gallbladder bile and in lumenal contents along the entire GIT. a Total bile acid levels (conjugated and unconjugated;
primary and secondary) and b the fraction of unconjugated bile acids in gallbladder bile and throughout the GIT (STM stomach; SI1 upper third
of the small intestine (SI), SI2 middle third of the SI, SI3 lower third of the SI roughly corresponding to the duodenum, jejunum, and ileum
respectively; CEC cecum; COL colon). In all plots, individual data points are overlaid onto box-and-whisker plots; whiskers extend from the
quartiles (Q2 and Q3) to the last data point within 1.5 × interquartile range (IQR). Multiple comparisons were performed using the Kruskal–Wallis
test; pairwise comparisons were performed using the Wilcoxon–Mann–Whitney test with FDR correction. N = 6 mice per group
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strates, we specifically wished to analyze whether the differ-
ences we observed in small intestine microbiota (Figs. 2 and
3) between coprophagic and non-coprophagic mice would
result in pronounced effects on microbial deconjugation of
bile acids. We also wished to test whether any differences
in bile acid deconjugation were in agreement with the
differences in the absolute BSH gene content we inferred
(Fig. 4a) from the absolute microbial abundances (Fig. 3c).
We first confirmed that in all four experimental groups,
total bile acids levels (conjugated and unconjugated; pri-
mary and secondary) across all sections of the GIT were
highest in the small intestine (Fig. 5a). We then compared
the levels of conjugated and unconjugated (Fig. 5b) as well
as primary (host-synthesized) and secondary (microbe-
modified) bile acids (Additional file 1: Figure S5) between
coprophagic and non-coprophagic mice.
Across all sections of the GIT and in the bile, non-
coprophagic mice (TC-F) had significantly lower levels of
unconjugated bile acids compared with coprophagic mice
(Fig. 5b). Consistent with the computational inference in
Fig. 4a (performed on mid-SI samples only), in all three
sections of the small intestine of non-coprophagic mice
(TC-F), the levels of unconjugated bile acids were substan-
tially lower than in coprophagic mice. Almost 100% of the
total bile acid pool remained in a conjugated form in the
small intestine of non-coprophagic mice.
In all groups of coprophagic mice (TC-M, WF, and
CTRL) the fraction of unconjugated bile acids gradually
increased from the proximal to distal end of the small
intestine. Gallbladder bile acid profiling (Fig. 5b) con-
firmed that bile acids were secreted into the duodenum
predominantly in the conjugated form in all coprophagic
mice. This pattern is consistent with the hypothesis that
the exposure of bile acids to microbial deconjugation ac-
tivity increases as they transit down a small intestine
with high microbial loads (Fig. 2a) [54].
In the large intestine, non-coprophagic (TC-F) mice car-
ried a smaller fraction of unconjugated bile acids com-
pared with all coprophagic experimental groups (Fig. 5b).
Bile acid deconjugation in the small intestine of copro-
phagic mice was uniform for all glyco- and tauro-
conjugates of all primary and secondary bile acids measured
in our study (Additional file 1: Table S7), suggesting a
broad-specificity BSH activity was provided by a complex
fecal flora in the small intestine of those animals.
In the gallbladder bile and across all segments of the
GIT from the stomach to the cecum, non-coprophagic
mice had a statistically significantly lower fraction (but not
lower absolute levels) of total secondary bile acids (conju-
gated and unconjugated) than coprophagic mice (Add-
itional file 1: Figure S5). This change was uniform for the
entire secondary bile acid pool of those analyzed (Add-
itional file 1: Table S7). The only segment of the gut inwhich the difference in the fraction of secondary bile acids
was not statistically significant between coprophagic and
non-coprophagic mice was the colon. In fact, the differ-
ences in the fractions of total unconjugated and total sec-
ondary bile acids between coprophagic and non-
coprophagic mice would have gone largely undetected had
we only analyzed colonic contents or stool. These findings
further highlight the importance of the comprehensive
spatial interrogation of the complex crosstalk between the
microbiota and bile acids in the gastrointestinal tract.
Discussion
In this study, we used modern tools for quantitative micro-
biota profiling and showed that when self-reinoculation
with fecal flora is prevented, the mouse small intestine har-
bors dramatically lower densities of microbiota and an al-
tered microbial profile. Consistent with published literature
[16, 21, 28–32], we confirmed that single housing on wire
floors failed to prevent mice from practicing coprophagy
and that only functional tail cups reliably prevented the
self-reinoculation with fecal flora.
Despite its effectiveness, the tail cup approach has lim-
itations. Tail cups in their current design may not be
suitable for female rodents due to anatomical differences
leading to urine entering and remaining inside the de-
vices [57]. Animals need to be singly housed to prevent
them from gnawing on each other’s tail cups and caus-
ing device failure or injury. The tail cup approach may
be hard to implement in younger and actively growing
mice (e.g., before or around weaning). Some mice in our
study developed self-inflicted skin lesions from over-
grooming at the location where the tail cups come in
contact with the body at the animal’s hind end. Thus, we
concluded that the approach in its current implementa-
tion is limited to 2–3 weeks in adult animals.
Our device design reduced the risk of tail injury and ne-
crosis described in previous works [33] and allows for
emptying the cups only once every 24 h to reduce hand-
ling stress. Because host stress can affect the microbiota
[58] and other physiological parameters, we included a
mock tail cup group. Both TC-F and TC-M mice demon-
strated a similar degree of weight loss (Additional file 1:
Figure S3A) when compared with the WF and CTRL mice
despite similar food intake rates across all four groups
(Additional file 1: Figure S3B). Mice fitted with mock tail
cups (TC-M) had microbial patterns and bile acid profiles
similar to the CTRL mice, thus the effects on the upper
GIT microbiota and bile acid profiles that we observed in
non-coprophagic (TC-F) mice are not attributable to stress.
We believe that the tail cup approach is implementa-
ble in gnotobiotic settings (e.g., flexible film isolators
and individually ventilated cages), which can aid studies
that involve association of mice with defined microbial
communities or with human-derived microbiota.
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relevant to humans
Using quantitative microbiota profiling, our study dem-
onstrated that preventing self-reinoculation dramatically
reduced the total levels of several prominent taxonom-
ical groups of obligate anaerobes (e.g., Clostridiales, Bac-
teroidales, Erysipelotrichale) in the upper gastrointestinal
microbiota of conventional mice. Despite these differ-
ences in taxa, levels of Lactobacillales in the small intes-
tine and cecum, but not in the stomach, remained
similar between coprophagic and non-coprophagic ani-
mals (Fig. 3c). The physiological significance of the
maintained persistent population of Lactobacillales in
the upper gastrointestinal tract (e.g., stomach or small
intestine) and their overall consistent presence along the
entire GIT [14, 59] for the host is not fully understood.
However, Lactobacilli colonization in the stomach and
small intestine has been shown to promote resistance to
colonization by pathogens (reviewed in [60, 61]).
Compared with conventional (coprophagic) mice, the
non-coprophagic mice displayed features of the small in-
testine microbiota and bile acid profiles that are more
similar to the patterns seen in the small intestine of
humans: orders of magnitude lower microbiota density,
reduced abundance of obligate anaerobic flora and dom-
inance of Lactobacillales, and a higher ratio of conju-
gated bile acids. These findings highlight the need to
understand and control self-reinoculation in mouse
models used to answer questions relevant to host-
microbiota interactions in human health.
Self-reinoculation and microbial ecology in the mouse GIT
We observed that within the approximately 2-week
timeframe of our study, the taxonomical diversity of the
mouse large intestine microbiome was stable in the ab-
sence of persistent microbial self-reinoculation: all taxo-
nomical groups at the order level observed in the cecum
of coprophagic mice were present in the cecum of non-
coprophagic mice, and vice versa.
The trending changes in the absolute abundances of
several taxa (Bacterodales, Erysipelotrichales, and Beta-
proteobacteriales) in the large intestine of non-
coprophagic mice may be the result of eliminated self-
reinoculation and/or the consequence of the altered pro-
file of bile acids entering the cecum from the small in-
testine, or other undetected changes in the biochemical
environment. Additionally, changes in the absolute
abundance of some taxa may lead to changes in the ab-
solute abundances of other metabolically coupled taxa. It
has been previously suggested that the degree of bile
acid deconjugation may alter the microbiota profile [46].
Erysipelotrichales (including Turicibacter spp.) in the
mouse ileum and cecum have been shown to be posi-
tively correlated with unconjugated ileal and cecal [62]and plasma [63] bile acids. Bacteroidales (including
Muribaculum spp.) in the cecum increased upon dietary
supplementation of unconjugated cholic and cheno-
deoxycholic acids [64] and Betaproteobacteriales (includ-
ing Parasutterella spp.) were positively correlated with
unconjugated primary and secondary bile acids [65, 66]
in mice. Thus, the decrease in the fraction of unconju-
gated bile acids in the large intestine of non-coprophagic
mice (Fig. 5b) may be responsible for the decreased ab-
solute abundance of these three taxonomic groups in the
cecum of non-coprophagic mice. It is of note that most
of the published reports describe correlations between
bile acid profiles and microbiota composition based on
relative abundance data and without accounting for the
inherent compositionality of relative abundance data
[67], which is known to introduce inaccuracies in the
correlation analysis [64, 68]. For improved correlation
analysis, our study reports absolute abundances of the
taxa, which could lead to discrepancies between such
correlations observed in this study and previously pub-
lished studies.
Stability of complex microbiomes in response to per-
turbations with and without continuous species reintro-
duction is an important subject of research in microbial
ecology [69, 70]. Eliminating fecal ingestion provides a
way to study stability and recovery of the mouse gut
microbiota (e.g., in response to dietary change or anti-
biotic exposure [71]) in a way more relevant to modern
humans. Thus, the non-coprophagic mouse model can
significantly aid such research.
Self-reinoculation with fecal flora leads to altered bile
acid profiles in the GIT
We demonstrated that changes to small intestine micro-
biota density and composition had pronounced effects
on microbial function resulting in increased bile acid
deconjugation in that segment of the GIT. Bile acid
deconjugation is a microbiota-mediated process that in
healthy humans is conventionally believed to take place
in the distal small intestine (ileum) and in the large in-
testine [72] such that sufficient lipid emulsification (with
conjugated bile acids) and absorption can take place in
the small intestine by the time digesta reaches the ileum
[73]. As a result of the much higher bile acid concentra-
tions in the small intestine compared with the large in-
testine, altered deconjugation of bile acids in the small
intestine may have more wide-ranging effects on the en-
tire enterohepatic system. Our data indicate that bile
acid deconjugation can take place in any segment of the
small intestine of conventional healthy mice as a func-
tion of the microbial density and composition (Figs. 2a,
3 and 5b), which is consistent with previous findings in
animal models and in humans with small intestinal bac-
terial overgrowth (SIBO) [74–78].
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in the small intestine of non-coprophagic mice in our
study resembles profiles seen in germ-free animals [79–
81], gnotobiotic animals colonized only with microbes
incapable of deconjugating bile acids [82–85], and
antibiotic-treated animals [86–88]. Our observations sug-
gest a mechanistic link between the small intestine micro-
biota density and composition and the bile acid
modification in this segment of the GIT. The small intes-
tine of healthy human subjects is believed to harbor bile
acids predominantly in the conjugated form [89], which
further substantiates that (compared with coprophagic
mice) the small intestine of non-coprophagic mice is more
similar to the small intestine of a healthy human.
Although microbiota density and composition in the
large intestine of coprophagic and non-coprophagic
mice were largely similar, non-coprophagic mice had a
higher fraction of bile acids that remained in the conju-
gated form in the large intestine (Fig. 4b), likely as a re-
sult of the bile acids entering the large intestine from
the ileum predominantly in a conjugated form. Add-
itionally, across all study groups, the total concentrations
of bile acids in the small intestine were ~ 10-fold greater
than in the large intestine. We therefore infer that in
coprophagic mice, a greater absolute amount of bile
acids underwent deconjugation in the small intestine
than in the large intestine; i.e., in coprophagic mice, the
small intestine contaminated with high loads of fecal
flora was the primary site of bile acid deconjugation.
Regulation of bile acid deconjugation activity in the
gut is considered a potential health-promoting modality
in a number of contexts, including lowering blood chol-
esterol levels (reviewed in [90–92]). BSH-active probio-
tics can be a promising delivery vehicle for promoting
increased bile acid deconjugation in the gut. Our study
emphasizes the importance of controlling for self-
reinoculation when using mice to study the effects of
BSH-active microbial strains or probiotics [48, 93–98]
(especially those with high selectivity for particular bile
acid conjugates [47, 82, 85]) because conventional
(coprophagic) mice already have pronounced BSH activ-
ity in their small intestines. A non-coprophagic mouse
may be a better animal model in such studies.
Our findings also have implications for the use of con-
ventional (coprophagic) mice in diet studies. Deconjugated
bile acids are less effective than conjugated bile acids at
lipid emulsification and fat micelle formation [74, 99]. In-
creased bile acid deconjugation in the small intestine of
animals and humans can lead to lipid malabsorption and
fat-soluble vitamin deficiency, and in extreme scenarios
even to steatorrhea [77, 100]. Previous research has shown
that the small intestine microbiota plays an important role
in mediating the effect of high-fat diets on the host [101];
our results suggest that future studies of the microbiota-mediated effects of high-fat diets need to consider in-
creased microbial bile acid deconjugation in the mouse in-
testine due to self-reinoculation with fecal flora.
Bile acid deconjugation is considered to be obligatory
[84, 102, 103] before the secondary bile acid metabolism
(believed to be predominantly occurring in the large in-
testine [72]) can take place. These reactions in many
cases are carried out by different members of the micro-
biota. Thus, the reduction of the deconjugation activity
in the small intestine of non-coprophagic mice and con-
sequently lower availability of free primary bile acids for
further microbial modification can explain the decrease
in the secondary bile acid fraction (percentage of all bile
acids) in the bile acid pool across the GIT and gallblad-
der bile of non-coprophagic mice in our study. A similar
but more pronounced trend has been observed in rabbits
[104]. Reduced oral intake and recycling of fecal second-
ary bile acids as a result of eliminating coprophagy may
also be a contributing factor to the lower fraction of sec-
ondary bile acids in the total bile acid pool in the entero-
hepatic circulation in these animals.
Total bile acid levels in the stomach were similar in
coprophagic and non-coprophagic mice (and agree with
literature [104, 105]); however, bile acid profiles (includ-
ing the fraction of total unconjugated and total second-
ary bile acids) were substantially different. Surprisingly,
in all coprophagic mice the fraction of unconjugated bile
acids in the stomach appeared to be intermediate be-
tween the profiles in the small intestine and in the large
intestine (Fig. 5b), suggesting that the bile acids in the
stomach of coprophagic mice could be accumulating
from bile acids re-ingested in feces and bile acids
refluxed from the duodenum. This pattern was not ob-
served in non-coprophagic mice, suggesting that
coprophagy may alter the bile acid profile in the upper
GIT both directly (via re-ingestion of fecal metabolites)
and indirectly (via altered microbiota function).
Inferences about microbial function in bile acid and drug
modification
Our quantitative functional gene inference analysis pre-
dicted differential absolute abundance of the BSH ortho-
logs between the small intestine of coprophagic and
non-coprophagic mice (Fig. 4a). This approach has limi-
tations associated with incomplete gene annotations,
limited ability to infer metagenomes from the marker
gene sequences when multiple microbial strains with
similar 16S rRNA gene sequences exist [44, 45], diffi-
culty to predict the exact gene expression and enzyme
activity and specificity. To test our prediction about BSH
we employed a targeted bile acid metabolomic analysis
of mouse gastrointestinal samples and observed the dif-
ferences in the small intestine bile acid deconjugation be-
tween coprophagic and non-coprophagic mice (Fig. 5b)
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ferred BSH gene abundances in the small intestine of
those two types of animals (Fig. 4a). Interestingly,
despite similar inferred BSH gene abundance in the
cecum of coprophagic and non-coprophagic mice, the
fraction of unconjugated bile acids in the cecum and
colon of non-coprophagic mice was statistically sig-
nificantly lower (Fig. 5b) compared with coprophagic
mice.
Michaelis–Menten constants (Km) for many known
BSH isoforms are in the range of hundreds of nanomoles
[72]—similar to the levels of bile acids observed in the
small intestine of all groups of mice in this study (Fig.
5a). Total bile acid levels in the cecum and colon were
~ 10-fold lower than those in the small intestine, and
thus they were ~ 10-fold lower than the BSH Km (Fig.
5a). The predominantly conjugated form of the bile acids
arriving into the cecum from the small intestine of non-
coprophagic mice and their absolute concentration (~
10-fold lower than BSH Km) can potentially explain the
lower degree of bile acid deconjugation in the large in-
testine of these animals (compared with coprophagic
mice) on the timescale of normal gastrointestinal transit.
This highlights the importance of considering func-
tional inference (based on either taxonomy or in silico
hidden state prediction [44, 45, 106, 107]) in the context
of a variable biochemical environment (e.g., substrate
availability) and the host gastrointestinal physiology (se-
cretion, gastrointestinal transit, absorption and trans-
port, etc.) and warrants functional validation (e.g.,
metabolomics). Additionally, the validity of functional
inference based on 16S rRNA gene sequence counts
(from next generation sequencing) versus absolute 16S
rRNA gene sequence abundances (this study) should be
further explored in future work.
We next explored the effects of self-reinoculation on
the absolute abundance of microbial gene orthologs im-
plicated in xenobiotic modification [108] in the small in-
testine, as microbiota-dependent drug modification and
toxicity in the small intestine have been previously ob-
served in rodents [109–119]. Many drugs administered
to humans and mice both via enteral and parenteral
routes after reaching the systemic circulation are trans-
formed by the liver into conjugates (e.g., glucuronic acid,
sulphate, or glutathione conjugates) and excreted with
bile into the GIT lumen. Such transformations are be-
lieved to reduce the small intestine reabsorption of xe-
nobiotics and promote their excretion from the body
with stool. Alterations in the small intestine microbiota
may also lead to increased hydrolysis of such conjugates
by microbial enzymes and promote the local toxicity of
the drug and enable its re-uptake from the small intes-
tine (i.e., undergo enterohepatic circulation) [10, 116],
resulting in an increase in the xenobiotic flux throughthe liver [120, 121] and to an overall microbiota-
dependent change in drug pharmacokinetics.
As with the inferred differential BSH absolute abun-
dances (correlating activity of which we confirmed with
the bile acid deconjugation measurements), our analysis
predicted differences in the absolute abundance (Fig. 4b,
c) of the microbial gene orthologs responsible for drug
conjugate hydrolysis (e.g., beta-glucuronidases, sulfohy-
drolases) between the small intestine of coprophagic and
non-coprophagic mice. If this prediction is further ex-
perimentally confirmed, it would imply that self-
reinoculation must be controlled for or taken into ac-
count when investigating drug pharmacology in mice.
Relevance of self-reinoculation in probiotics research
Many studies on probiotics and their effects on host ani-
mal physiology rely on repeated oral administration of
live probiotic microorganisms to rodents. Our study sug-
gests that self-reinoculation with live fecal flora in la-
boratory mice could both interfere with and introduce
inconsistencies in live probiotic administration regimens.
As has been stated earlier, particular attention should be
given to self-reinoculation and its effects on the small in-
testine bile acid profile in studies aiming to evaluate the
health effects of probiotics and other therapeutic modal-
ities [48, 90–98] targeting bile acid deconjugation and
metabolism.
Relevance of mouse models in human microbiota
research
The role of mouse models in human microbiota research
remains a subject of debate [13, 14, 122]. At the same
time, the field is recognizing the importance of reprodu-
cibility in gut microbiota research that uses mouse
models [58, 122]. Several recent studies have highlighted
the variability in lab-mouse microbiota related to animal
strains and sources of origin [36, 123–127]. Others have
attempted to catalog a “normal” or “core” gut micro-
biome [128, 129] and its spatial organization [35, 36]
and function [130] in laboratory and wild mice. Recently,
the small intestine microbiome has become the focus of
studies conducted in mice in the context of host physi-
ology [101] and disease [4, 131]. Yet, little attention has
been given to the impact of self-reinoculation on the gut
microbiota spatial structure and function, or to how
study outcomes might be affected by controlling (or not
controlling) for this experimental parameter in mouse
models.
Self-reinoculation in rodents may affect not only their
native microbiota, but also individual microbial colo-
nizers [24] (e.g., in gnotobiotic animals) and complex
xenomicrobiota (e.g., in human microbiota-associated
(HMA) mice). HMA mice have emerged as an important
research model for dissecting the mechanistic
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phenotype in health and disease, even though the field
acknowledges its limitations [132, 133]. Compositional
differences between the small intestine and large intes-
tine microbiomes in primates and humans [12, 40, 41]
appear to be more substantial than those reported for la-
boratory mice [35, 130]. Our study emphasizes that the
compositional similarity between small and large intes-
tine microbiota in conventional laboratory mice can be a
result of self-reinoculation with fecal flora. Thus, the ef-
fects of self-reinoculation on the spatial organization and
function of human microbiota in HMA mice warrant fu-
ture exploration.Conclusions
In conclusion, this study uses modern tools to demon-
strate the importance of self-reinoculation in the context
of microbial ecology and function within the mammalian
gastrointestinal system. Our work highlights the import-
ance of recognizing and properly controlling for self-
reinoculation when murine studies analyzing small intes-
tine microbiota, and its function intend to draw parallels
with human physiology and pathophysiology. Addition-
ally, spatial interrogation of the gut microbiota and its
function in mouse models is important because even
dramatic changes in the small intestine microbiome pro-
file, function, and metabolome may be overlooked if only
large intestine and stool samples are analyzed.Methods
Experimental animals
All animal handling and procedures were performed in
accordance with the California Institute of Technology
(Caltech) Institutional Animal Care and Use Committee
(IACUC). C57BL/6 J male specific-pathogen-free (SPF)
mice were obtained at the age of 7–8 weeks from Jack-
son Laboratory (Sacramento, CA, USA) and housed four
mice per cage. Two cohorts of animals were used: the
first cohort was allowed to acclimate in the Caltech ani-
mal facility for 2 months and mice were 4 months old at
the start of the study; the second cohort acclimated for
6 months and mice were 8 months old at the start of the
study.
All animals were maintained on chow diet (PicoLab
Rodent Diet 20 5053, LabDiet, St. Louis, MO, USA) and
autoclaved water ad lib and subjected to a daily 13:11
light:dark cycle during acclimation and throughout the
entire study. Mice were given measured amounts of
food, and food intake during the experiment was mea-
sured by weighing the food during weekly cage changes
and at the end time point for each animal. Body weight
was measured at the start of the experiment, during
weekly cage changes, and at the end time point.Animal housing conditions
During the experiment, all mice were singly housed in
autoclaved cages (Super Mouse 750, Lab Products, Sea-
ford, DE, USA). The mice in the control (CTRL), mock
tail cup (TC-M), and functional tail cup (TC-F) treat-
ments were housed on heat-treated hardwood chip bed-
ding (Aspen Chip Bedding, Northeastern Products,
Warrensburg, NY, USA) and provided with tissue paper
(Kleenex, Kimberly-Clark, Irving, TX, USA) nesting ma-
terial. The mice in the WF treatment were housed on
raised wire floors with a mesh size of 3 × 3 per square
inch (#75016, Lab Products) and provided with floorless
paper huts (#91291, Shepherd Specialty Papers, Water-
town, TN, USA). A thin layer of woodchip bedding was
added under the wire floors to absorb liquid waste from
the animals (Additional file 1: Figure S1D).
Tail cup design and mounting
We designed the tail cups based on published literature
[30, 134–137], including the locking mechanism [30].
Each cup was locked in place around the hind end of an-
imals by anchoring to a tail sleeve designed with a per-
pendicular groove. Such tail sleeves allow for the cup to
be held snugly against the animal so that the total weight
of the tail cup is distributed along a large surface area of
the tail skin, which minimizes complications. When
mounted, the tail cups can freely rotate along the longi-
tudinal axis, which ensures the locking mechanism does
not strangulate the tail.
We hand-made the tail cups from 20 mL syringes
(#4200.000 V0 Norm-Ject 20 mL Luer-Lock, Henke-Sass
Wolf GmbH, Tuttlingen, Germany) as depicted on Add-
itional file 1: Figure S1A-C. Multiple perforations were
designed to accelerate desiccation of the captured fecal
pellets. Lateral slits allowed for increasing the diameter
of the locking edge; pressing on the slits with two fingers
allowed tail cups to be quickly unfastened from tail
sleeves. Mock tail cups were modified with wide gaps in
the walls to allow the fecal pellets to fall out of the cup.
To prevent mice from gnawing on the plastic parts of
the tail cups (which could create a jagged edge and lead
to a subsequent injury), they were reinforced with metal
flared rings made from stainless steel grommets
(#72890, SS-4, C.S. Osborne, Harrison, NJ, USA) that
were modified to reduce their size and weight. Metal
rings were attached to tail cups using 4-mm-wide rubber
rings cut from latex tubing (Amber Latex Rubber Tub-
ing #62996–688, 1/2″ ID, 3/4″ OD; VWR, Radnor, PA,
USA).
Tail sleeves were made from high-purity silicone tub-
ing (HelixMark 60–411–51, 1/8“ ID, 1/4” OD; Helix
Medical, Carpinteria, CA, USA). The tubing was split
longitudinally, and a 2.0-mm-wide longitudinal strip of
the wall was removed to accommodate for variable tail
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tail to prevent uneven tail compression, and to facilitate
uniform application of the tissue adhesive. The perpen-
dicular tail cup mounting groove was made using a rotary
tool (Craftsman #572.610530, Stanley Black & Decker,
New Britain, CT, USA) equipped with a cutting disc (RD1,
Perma-Grit Tools, Lincolnshire, UK). Each tail cup and
sleeve together weighed approximately 4.12 g empty.
Before mounting the tail cups, animals were anesthe-
tized for 10 min with isoflurane and placed on a heating
pad to maintain body temperature. Sleeves were de-
greased on the inside using 70% ethanol, and a veterin-
ary tissue adhesive (GLUture Topical Adhesive #32046,
Abbott Laboratories, Lake Bluff, IL, USA) was applied to
the tail base. The adhesive was allowed to cure for
5 min, and then tail cups were mounted. Mice were
returned back to their cages and allowed to recover from
the anesthesia and ambulate.
Tail cups were emptied of fecal pellets daily at 08:
00 AM. Mice were prompted to enter a restrainer [138]
made from a black polypropylene 50-mL conical tube
(TB5000 LiteSafe, Cole-Parmer, Vernon Hills, IL, USA),
and the tail cups were unclipped and quickly emptied.
Any residue on the tail cup was cleaned using a paper
towel and Rescue solution (Virox Technologies, Oakville,
ON, Canada) prior to the cups being remounted. Ani-
mals fitted with the mock tail cups were subjected to the
identical procedure to match the handling conditions.
Tail cups were mounted on animals for a duration of
between 12 and 20 days. All TC-F animals were time-
matched with TC-M animals, (i.e., each animal from the
TC-F group had a time-matched animal from the TC-M
group handled and euthanized at the same time).
Sample collection and treatment
All mice were euthanized as approved by the Caltech
IACUC in accordance with the American Veterinary
Medical Association Guidelines on Euthanasia [139].
Mice were euthanized while under isoflurane anesthesia
(delivered via a calibrated gas vaporizer in an induction
chamber followed by maintenance on a nose cone) via
cardiac puncture followed by cervical dislocation. Blood
was collected using a 1-mL syringe (#309659, Becton
Dickinson) and 21G × 1″ needle (#26414, EXELINT
International, Redondo Beach, CA, USA).
Blood was immediately placed into K2EDTA plasma
separation tubes (MiniCollect 450480, Greiner Bio-One
GmbH, Kremsmünster, Austria), gently mixed, and
stored on ice for up to 1 h prior to centrifugation. Bile
and urine were collected directly from the gall and urin-
ary bladders respectively using a 1-mL syringe
(#4010.200 V0 Norm-Ject 1-mL Tuberculin Luer,
Henke-Sass Wolf GmbH) and 27G × 1/2″ needle
(#26400, EXELINT International) and stored on ice.Fecal samples were collected if present at the time of
euthanasia. The entire gastrointestinal tract was excised
from the gastroesophageal junction to the anal sphincter
and stored on ice during processing.
Plasma separation
Blood samples were centrifuged in the plasma separation
tubes at 2000 RCF for 5 min at 4 °C. Plasma was sepa-
rated and stored at − 80 °C.
Processing of GIT contents
To prepare samples for the main experimental analyses
(Figs. 2, 3, and 4), each mouse GIT was split into stom-
ach, three-equal-length thirds of the small intestine,
cecum, and colon. Contents from each segment of the
GIT were flushed out using 2–5 mL of cold (4 °C) sterile
autoclaved saline solution (0.9% NaCl (#S5886, Sigma-
Aldrich) in ultrapure water (Milli-Q, MilliporeSigma,
Burlington, MA, USA) followed by very gentle squeezing
with tweezers to avoid mucosal damage. All samples
were stored on ice during processing.
An aliquot of each sample diluted in saline was con-
centrated by centrifugation at 25,000 RCF for 10 min at
4 °C. The supernatant was removed and the pellet was
reconstituted in 9 volumes of 1× DNA/RNA Shield
(DRS) solution (R1100-250, Zymo Research, Irvine, CA,
USA), mixed by vortexing and stored at – 80 °C for fu-
ture DNA extraction. Separate aliquots of each sample
were stored at − 80 °C for the metabolomic (bile acid)
analysis.
Preparation of GIT contents for the MPN-based micro-
bial quantification and 16S rRNA gene amplicon sequen-
cing (pilot study; Additional file 1: Figure S4B) was the
same as above, but conducted inside a vinyl anaerobic
chamber (Coy Laboratory Products, Grass Lake, MI, USA)
in an atmosphere of 5% hydrogen, 10% carbon dioxide,
and 85% nitrogen. All samples were maintained on ice
and immediately processed for the culture-based assay.
Preparation of GIT mucosa
After flushing its contents, each segment of the GIT was
gently rinsed in sterile cold (~ 4 °C) saline, cut longitu-
dinally, and placed flat on a glass slide. The mucosa was
scraped from the tissue gently using a second clean glass
slide. Glass slides (VistaVision #16004-422, VWR) were
sterilized by dry heat sterilization at 200 °C for at least
2 h. Mucosal scrapings were collected and combined
with 9 volumes of DRS solution, mixed by vortexing,
and stored at − 80 °C in preparation for DNA and RNA
extraction.
Most probable number (MPN) assay
For the pilot study (Additional file 1: Figure S4A), the
MPN assays (adapted from [140–144]) were performed
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small intestine, cecum, and colon) from five mice fitted
with functional tail cups and five control mice. The
growth medium was brain heart infusion broth (Bacto
BHI, #237500, Becton Dickinson, Franklin Lakes, NJ,
USA), prepared in ultrapure water (Milli-Q), sterilized
by autoclaving, allowed to cool to room temperature,
and supplemented with 1.0 mg/L vitamin K1 (#L10575,
Alfa Aesar, Haverhill, MA, USA), 5 mg/L hematin
(#H3281, Sigma-Aldrich St. Louis, MO, USA), and
0.25 g/L L-cysteine (#168149, Sigma-Aldrich). The
medium was allowed to equilibrate inside the anaerobic
chamber for at least 24 h before use.
MPN assays were performed in clear, sterile, non-
treated polystyrene 384-well plates (Nunc 265202,
Thermo Fisher Scientific, Waltham, MA, USA). Two
series of eight consecutive 10-fold serial dilutions were
prepared from each sample in sterile autoclaved saline
solution (equilibrated inside the anaerobic chamber for
at least 24 h) on clear sterile non-treated polystyrene 96-
well plates (Corning Costar 3370, Corning, NY, USA).
We injected 10 μL of each serial dilution from each
series into four (eight total per dilution) culture-medium
replicates (wells) filled with 90 μL of the BHI-S broth
medium.
Plates were sealed with a breathable membrane
(Breath-Easy BEM-1, Diversified Biotech) and incubated
for 5 days at 37.0 °C inside the anaerobic chamber. The
plates were lidless for the first 24 h to facilitate uniform
gas equilibration, then from 24 h to the end of the incu-
bation period (120 h), a plastic lid was kept over the
plates.
At the end of the incubation, the plates were scanned
using a flatbed scanner (HP ScanJet 8250, Hewlett-
Packard, Palo Alto, CA, USA) in the reflective mode
with black background at 300 dpi resolution. The posi-
tive wells (replicates) were called by visually observing
each acquired high-resolution image. The MPN for each
sample was calculated using Microsoft Excel with the
“Calc_MPN” macro [145].
DNA extraction
DNA was extracted from thawed GIT contents and mu-
cosal sample aliquots preserved in DRS solution with the
ZymoBIOMICS DNA Miniprep Kit (D4300, Zymo Re-
search) according to the manufacturer’s instructions.
Samples were homogenized on a bead beater (MiniBead-
Beater-16, Model 607, Bio Spec Products, Bartlesville,
OK, USA) for 5 min at the default speed of 3450 RPM.
Quantitative recovery of DNA across multiple orders
of microbial loads in the samples was previously veri-
fied in [38, 39].
DNA yield and purity in the extracts was evaluated via
light absorbance (NanoDrop 2000c, Thermo FisherScientific) and via a fluorometric assay (Qubit dsDNA
HS Assay Kit Q32854, Thermo Fisher Scientific) on a
fluorometer (Invitrogen Qubit 3, Thermo Fisher
Scientific).
Quantitative PCR (qPCR) for 16S rRNA gene DNA copy
enumeration
The qPCR reactions were set up in triplicates for each
DNA sample. A single replicate reaction volume of
15 μL contained 1.5 μL of the DNA extracts combined
with the qPCR master mix (SsoFast EvaGreen Supermix,
#172-5200, Bio-Rad Laboratories, Hercules, CA, USA),
forward and reverse primers (synthesized by Integrated
DNA Technologies, San Diego, CA, USA; Additional file
1: Table S1) at a final concentration of 500 nM, and ul-
trapure water (Invitrogen UltraPure DNase/RNase-Free
Distilled Water 10977-015, Thermo Fisher Scientific).
Reactions were set up in white 96-well PCR plates
(#HSP9655, Bio-Rad Laboratories) sealed with a PCR
tape (#MSB1001, Bio-Rad Laboratories).
The standard curve was built for each qPCR run based
on the included series of 10-fold dilutions of the “stand-
ard” SPF mouse fecal DNA extract (with the quantified
absolute concentration of 16S rRNA gene copies using
digital PCR).
Amplification was performed with real-time fluores-
cence measurements (CFX96 Real-Time PCR Detection
System, Bio-Rad Laboratories). Thermocycling condi-
tions were used according to Additional file 1: Table S2.
The qPCR data files were analyzed using Bio-Rad CFX
Manager 3.1 (#1845000, Bio-Rad Laboratories) and the
Cq data were exported to Microsoft Excel for further
processing.
Digital PCR (dPCR) for absolute 16S rRNA gene DNA copy
enumeration
Droplet digital PCR (ddPCR) reactions were set up ac-
cording to [38, 39]. A single replicate reaction volume of
20 μL contained 2.0 μL of the DNA extracts combined
with the ddPCR master mix (QX200 ddPCR EvaGreen
Supermix, #1864033, Bio-Rad Laboratories), forward and
reverse primers (synthesized by Integrated DNA Tech-
nologies; Additional file 1: Table S1) at final concentra-
tion of 500 nM each, and ultrapure water (Thermo
Fisher Scientific).
Droplets were generated using DG8 cartriges
(#1864008, Bio-Rad Laboratories), droplet generation oil
(#1864006, Bio-Rad Laboratories), and DG8 gaskets
(#1863009, Bio-Rad Laboratories) on a QX200 droplet
generator (#1864002, Bio-Rad Laboratories) and ana-
lyzed using a QX200 Droplet Digital PCR System
(#1864001, Bio-Rad Laboratories) using droplet reader
oil (#1863004, Bio-Rad Laboratories). The ddPCR data
files were analyzed using QuantaSoft Software
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exported to Microsoft Excel for further processing.
Thermocycling conditions were used according to [38, 39]
and Additional file 1: Table S3. Amplification was performed
in PCR plates (#0030133374, Eppendorf, Hauppauge, NY,
USA) sealed with pierceable heat seals (#1814040, Bio-Rad
Laboratories) using PCR plate sealer (PX1, #1814000, Bio-
Rad Laboratories) on a 96-deep well thermocycler (C1000
Touch, #1841100, Bio-Rad Laboratories).
16S rRNA gene DNA amplicon barcoding for next-
generation sequencing (NGS)
PCR reactions were set up according to [38, 39], in tripli-
cates for each DNA sample. Single-replicate reaction vol-
umes of 30 μL contained 3 μL of the DNA extracts
combined with the PCR master mix (5PRIME HotMaster-
Mix, #2200400, Quantabio, Beverly, MA, USA), DNA inter-
calating dye (EvaGreen, #31000, Biotium, Fremont, CA,
USA) at the concentration suggested by the manufacturer
(× 1), barcoded forward and reverse primers (synthesized by
Integrated DNA Technologies; Additional file 1: Table S1)
at a final concentration of 500 nM each, and ultrapure
water (Thermo Fisher Scientific). Reactions were set up in
0.2-mL white PCR tubes (#TLS0851) with flat optical caps
(#TCS0803, Bio-Rad Laboratories). Thermocycling condi-
tions were used according to [38, 39] and Additional file 1:
Table S4. Amplification was performed with real-time fluor-
escence measurements (CFX96 Real-Time PCR Detection
System, Bio-Rad Laboratories) and samples were amplified
for a variable number of cycles until the mid-exponential
(logarithmic) phase to maximize the amplicon yield and
minimize artifacts related to over-amplification [146].
Digital PCR (dPCR) for Illumina library quantification
Single replicate reaction volume of 20 μL contained
2.0 μL of the diluted amplicon sample ligated with the
Illumina adapters, 10 μL of ddPCR master mix (QX200
ddPCR EvaGreen Supermix, #186-4033, Bio-Rad Labora-
tories), forward and reverse primers (synthesized by In-
tegrated DNA Technologies; Additional file 1: Table S1)
targeting the Illumina P5 and P7 adapters respectively at
the final concentration of 125 nM each, and ultrapure
water (Invitrogen). Thermocycling conditions were used
according to Additional file 1: Table S5. PCR amplifica-
tion and droplet analysis were performed as above.
Barcoded sample quantification, pooling, library
purification, and quality control
Triplicates of each barcoded amplicon sample were
combined. Each sample was diluted × 105–107-fold and
the molar concentration of barcoded amplicons was
quantified using a home-brew ddPCR library quantifica-
tion assay and KAPA SYBR FAST Universal qPCR Li-
brary Quantification Kit (#KK4824, Kapa Biosystems,Wilmington, MA, USA) according to the manufacturer’s
instructions (the qPCR reaction was set up same as
above).
Barcoded samples were pooled in equimolar amounts.
The pooled library was purified using Agencourt
AMPure XP beads (#A63880, Beckman Coulter, Brea,
CA, USA) according to the manufacturer’s instructions
and eluted with ultrapure water (Invitrogen).
The purified library was confirmed to have the
260 nm to 280 nm light absorbance ratio of > 1.8 using a
NanoDrop 2000c spectrophotometer (Thermo Fisher
Scientific). The average amplicon size of approximately
~ 400 bp was confirmed with a High Sensitivity D1000
ScreenTape System (#5067-5584 and #5067-5585, Agi-
lent Technologies, Santa Clara, CA, USA) using a 2200
TapeStation instrument (Agilent Technologies) and the
Agilent 2200 TapeStation Software A.02.01 (Agilent
Technologies).
The molar concentration of the pooled library was
measured using the ddPCR and KAPA qPCR assays, and
the library was submitted for NGS with the sequencing
primers described in Additional file 1: Table S1.
Next-generation sequencing
The library was sequenced on a MiSeq instrument (Illu-
mina, San Diego, CA, USA) in a 300-base-paired-end
mode using a MiSeq Reagent Kit v3 (#MS-102-3003,
Illumina). PhiX control spike-in was added at 15%.
PCR primer oligonucleotides (Additional file 1: Table S1)
The same universal microbial 16S rRNA gene V4
primers (modified from [147, 148] and validated in [38,
39] (Barlow JT, Bogatyrev SR, Ismagilov RF: A quantita-
tive sequencing framework for absolute abundance
measurements of mucosal and lumenal microbial com-
munities, submitted)) targeting the V4 region of the 16S
rRNA gene from the 519 to 806 positions were used for
16S rRNA gene DNA copy quantification and multi-
plexed microbial community profiling based on 16S
rRNA gene amplicon sequencing. Reverse barcoded
primers for 16S rRNA gene DNA amplicon barcoding
were according to [148].
Primers targeting the P5 and P7 Illumina adapters for
barcoded amplicon and pooled library quantification
using the ddPCR assay were according to [147–151].
Sequencing read processing
Demultiplexed 2 × 300 reads were processed using the
Qiime2-2019.01 pipeline [152]. DADA2 plugin [153] was
used to filter (forward trimming, 5; forward truncation,
230; reverse trimming, 5; reverse truncation, 160),
denoise, merge the paired-end sequences, and remove
the chimeras. Taxonomic sequence (amplicon sequence
variant, ASV) classification was performed using the
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[155] on the V4 515-806 bp regions of 16S rRNA gene
sequences from the Silva rRNA reference database, re-
lease 132 [156] (available for download from [157]).
Functional gene inference analysis with PICRUSt2 [44,
45] was performed on the ASVs within the Qiime2 en-
vironment. Absolute and relative abundances of ASVs
were normalized using the inferred 16S rRNA gene
DNA copy counts. Obtained predicted metagenome data
were used to calculate the normalized relative and abso-
lute abundances of the gene orthologs of interest using
Python tools (described below).
Sequencing data processing
Data handling, calculations, and statistical analyses were
performed using Microsoft Excel with the Real Statistics
Resource Pack [158], and the Python packages NumPy
[159], Pandas [160], SciPy [161], and Statsmodels [162].
Plotting was performed with Matplotlib [163] and Sea-
born [164]. All Python packages were run using IPython
[165] within Jupyter notebooks [166] distributed with
the Anaconda environment [167].
Frequency data for the 16S rRNA gene ASVs assigned
to taxa in each sample were converted to relative abun-
dances for each sample. Relative abundances then were
converted to absolute abundances using the correspond-
ing values of total 16S rRNA gene DNA loads obtained
from the qPCR and ddPCR assays for each sample.
Absolute abundance data were then collapsed to the
genus (Fig. 3a) or order (Fig. 3b, c) taxonomical levels
using a custom-made Python function (confirmed to
yield identical results to the “collapse” method of the
Qiime2 “Taxa” plugin [152]). We defined contaminating
taxa (from sample handling during collection or from
the DNA extraction kit or PCR reagents) using two
methods: taxa that were not present in at least 1 out of
16 cecum contents samples (4 mice out of 6 from each
group × 4 groups), and taxa identified with a frequency-
based contaminant identification [168] implemented by
us in Python. Data for chloroplasts and mitochondria of
plant origin (likely from the chow diet) were kept in the
dataset for Fig. 3a and c and removed for Fig. 3b. Mean
absolute abundances of taxa for each group were calcu-
lated, converted to relative abundances, and plotted in
Fig. 3b.
Principal component analysis (PCA) of the relative
abundance data (Additional file 1: Figure S4B) was per-
formed on centered log ratio (CLR)-transformed [169,
170] (after a pseudocount equal to the minimal non-
zero sequence count in the dataset was added to all zero
values) genus-level relative abundance data using the Py-
thon Scikit-learn package [171].
PCA of the absolute abundance data (Fig. 3a) was
performed on log10-transformed and centeredstandardized (converted to normally distributed data
with mean = 0 and standard deviation = 1) [172]
genus-level absolute abundance data using the Python
Scikit-learn package [171].
Bile acid analysis
Reagents
TαMCA, TβMCA, TωMCA, THCA, αMCA, βMCA,
ωMCA, HCA, HDCA, MCA, GCDCA, GDCA, and GCA
(Additional file 1: Table S6) were obtained from Stera-
loids (Newport, RI, USA).
TCA, CA, DCA, TCDCA, TDCA, TUDCA, TLCA,
CDCA, UDCA, LCA, D4-TCA, D4-DCA, D4-CA, D4-
TDCA, D4-GLCA, D4-GUDCA, D4-GCDCA, D4-GCA,
and D4-GDCA (Additional file 1: Table S6) were ob-
tained from Isosciences (Ambler, PA, USA).
LC/MS grade acetonitrile (#A955-500), water (#W6500),
and formic acid (#A117-50) were obtained from Thermo
Fisher Scientific.
Sample preparation
To overcome sample buffering (pH issues), samples were
extracted (using a protocol adapted and modified from
[83–85]) in 9 volumes of ethanol with 0.5% formic acid
and 9 different heavy isotope (D4) internal standards at
5 μM. D4 internal standards were taurocholic acid
(TCA), cholic acid (CA), deoxycholic acid (DCA), tauro-
deoxycholic acid (TDCA), glycocholic acid (GCA), glyco-
lithocholic acid (GLCA), glycoursodeoxycholic acid
(GUDCA), glycochenodeoxycholic acid (GCDCA), and
glycodeoxycholic acid (GDCA). Samples were heated for
1 h at 70 °C with orbital shaking at 900 RPM. Solids
were precipitated by centrifugation at 17,000 RCF for
15 min at 4 °C. Supernatants were decanted as 10% of
the original sample (e.g., 100 μL of a 1-mL extraction
sample) and evaporated at approximately 100 mTorr at
RT on a rotovap (Centrivap Concentrator #7810016,
Labconco, Kansas City, MO, USA). The evaporated sam-
ples were reconsistuted at 100 × dilution from the ori-
ginal sample (e.g., 100 μL decanted solution is
resuspended at 1 mL) in 20% acetonitrile, 80% water
with 0.1% formic acid.
Due to small volumes, gall bladder bile samples were
first diluted in 10 volumes of 100% ethanol (#3916EA,
Decon Labs, King of Prussia, PA, USA). The ethanol-
based dilutions were combined with 9 volumes of ultra-
pure water (Invitrogen) and subjected to extraction as
above.
Each 10-μL extracted and reconsistuted sample injec-
tion was analyzed on a Waters Acquity UPLC coupled
to a Xevo-qTOF Mass Spectrometer (Waters, Manches-
ter, UK) using an Acquity UPLC HSS T3 1.8 micron,
2.1 × 10-mm column (# 186003539) and Acquity UPLC
HSS T3 1.8 micron Guard Column (# 186003976).
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and one part acetonitrile. Purge solvent was 5% aceto-
nitrile in water. A pooled quality control sample was run
every eight injections to correct for drift in response.
Mass spectrometer instrument parameters were as fol-
lows: Capillary Voltage 2.4 kV, Collision Energy 6.0 eV,
Sampling Cone 90 V, Source Offset 40 V, Source 120 °C,
desolvation gas temperature 550 °C, cone gas 50 L/h,
and desolvation Gas 900 L/h. Time-of-flight mass spec-
tra were collected in resolution mode, corresponding to
30,000 m/Δm. The mass axis was calibrated with sodium
formate clusters and locked using leucine enkephalin.
A seven point external calibration curve was collected
three times within the run from 0.05 to 30 μM of the
bile acid standards (0.05, 0.1, 0.5, 1, 5, 10, and 30 μM).
External standards were taurocholic acid (TCA), tauro-
alpha-muricholic acid (TαMCA), tauro-beta-muricholic
acid (TβMCA), tauro-omega-muricholic acid (TωMCA),
tauro-hyocholic acid (THCA), tauro-deoxycholic acid
(TDCA), tauro-ursodeoxycholic acid (TUDCA), tauro-
chenodeoxycholic acid (TCDCA), taurolithocholic acid
(TLCA), glyco-cholic acid (GCA), glyco-hyocholic acid
(GHCA), glyco-deoxycholic acid (GDCA), glyco-
hyodeoxycholic acid (GHDCA), cholic acid (CA), alpha-
muricholic acid (αMCA), beta-muricholic acid (βMCA),
omega-muricholic acid (ωMCA), hyocholic acid (HCA,
also known as γ-muricholic acid), deoxycholic acid
(DCA), chenodeoxycholic acid (CDCA), ursodeoxycholic
acid (UDCA), hyodeoxycholic acid (HDCA), murocholic
acid (murideoxycholic acid, MDCA), lithocholic acid
(LCA), glycolithocholic acid (GLCA), glycourosodeoxy-
cholic acid (GUDCA), and glycochenodeoxycholic acid
(GCDCA). It was not possible to resolve UDCA and
HDCA; so the sum was reported.
Integrated areas of extracted ion chromatograms were
obtained using QuanLynx (Waters, Milford, MA, USA)
and a mass extraction window of 10 mDa. Final correc-
tions accounting for drift in instrumental sensitivity were
performed in Microsoft Excel.
Elution gradient
Samples were eluted using the following gradient of
water with 0.1% formic acid (“A”) and balance of aceto-
nitrile with 0.1% formic acid:
1. 0 min, 0.55 mL/min at 68% A
2. 2 min, 0.55 mL/min at 60% A, 10 curve
3. 5 min, 0.55 mL/min at 40% A, 5 curve
4. 6 min, 1.1 mL/min at 0% A, 10 curve
5. 6.2 min, 1.2 mL/min at 0% A, 6 curve
6. 6.5 min, 1.47 mL/min at 0% A, 6 curve
7. 8.9 min, 1.5 mL/min at 0% A, 6 curve
8. 9.0 min, 0.9 mL/min at 68% A, 6 curve
9. 10 min, 0.55 mL/min at 68% A, 6 curveBile acid data processing
Bile acid data analysis was performed using the tools
described in “Sequencing data processing.”
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